# Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance

> **NCT01819389** · PHASE3 · COMPLETED · sponsor: **Hospital Universitario Dr. Jose E. Gonzalez** · enrollment: 10 (actual)

## Conditions studied

- Leukemia, Myeloid, Chronic, BCR-ABL Positive

## Interventions

- **DRUG:** Imatinib and Nilotinib

## Key facts

- **NCT ID:** NCT01819389
- **Lead sponsor:** Hospital Universitario Dr. Jose E. Gonzalez
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01819389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01819389, "Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01819389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*